This story was first published in digitalhealth.net
Breath test device on trial for Cancer
A spin off firm from Cambridge University, Owlstone, has developed the Lung Cancer Indicator Detection (LuCID) device to detect chemical traces in breath which indicate a patient may have cancer.
Billy Boyle, co-founder of the firm, told Sky News in the UK a handheld device could be made available to GPs within two years.
He said he began to look at medical applications of the company's technology, originally intended to detect explosives, when his wife Kate Gross was diagnosed with colon cancer two years ago before she died at 36 on Christmas Day.
"The human body makes chemicals, a lot of them are just normal, everyday chemicals, but with cancer and other diseases the cells go a bit wrong and start to make chemicals differently," Mr Boyle told the broadcaster.
"So by programming the chips in software to look for these different characteristic signatures and chemical markers you can program it to look for a range of different diseases.
"We already have the microchip, we're working on small handheld devices in (a) GP's office. It's important to get the clinical evidence first but we think we can have systems available, proven, within the next two years.
"And our goal is to save the NHS (National Health Service) STG245 million ($A477.63 million) - but more importantly to save 10,000 lives."
Mr Boyle added he hoped the technology would lead to earlier detection of lung cancer, which kills more than 35,000 annually in the UK and has a low survival rate because diagnosis is often at the terminal stage.
The firm is to run trials at Glenfield Hospital in Leicester and one other. A desktop version of the "breathalyser" already exists and will be used in the clinical trials.
Last year researchers, including a team from the University of Liverpool, discovered subtle genetic changes in vapour given off by cells that suggested a diagnostic breath test for lung cancer was theoretically possible.
Latest News
16/02/2024 - 12:56
Hammersmith and Fulham Council has created a new alliance intended to clean dirty air and improve residents' health.
16/02/2024 - 10:44
Two million more GP appointments a month are being delivered for patients compared to the same month before the pandemic as part of the NHS primary care access recovery plan according to new NHS data.
15/02/2024 - 10:26
The Welsh Government has provided innovation funding of £380,000 to support two projects utilising technology in domiciliary care.
15/02/2024 - 10:13
The new Scottish health secretary has met with frontline staff at Queen Elizabeth University Hospital in Glasgow.
14/02/2024 - 10:27
The North East London NHS Foundation Trust (NELFT) has appointed three new Executive Directors to the Trust Board.
Product Features
UK Building Regulations highlight toxic gas and smoke from layers of paint built up over multiple redecorations as a major cause of permanent ill health or death in a building fire.
Their concern rose with discovery the flame retardant paints most widely used paint along escape routes have been ones which to this day counter-productively use emission of heavy toxic gas to smother flames which rapidly spread along walls if layers of paint delaminate in a fire.
Supplier Profiles
Northwich’s Victoria Infirmary (VIN) Community Diagnostic Centre (CDC) has enabled more patients
Adveco, the commercial hot water specialist, announces the launch of live metering of domestic ho
Latest Features
Sarah Greenslade, public affairs and communications officer at the British Parking Association looks at some of the problems and innovations in healthcare parking
It’s easy to assume that the comms team is there to handle press enquiries and the occasional social media storm – but the reality is that strategic communications can make a measurable impact across the entire organisation, from operational to financial, when done properly
